Abstract
The Onchocerciasis Elimination Program for the Americas (OEPA) is a regional initiative and international partnership that has made considerable progress toward its goal since it was launched in 1993. Its strategy is based on mass drug administration of ivermectin (Mectizan, donated by MSD, also known as Merck & Co., Inc., Kenilworth, NJ, USA), twice or four times per year, with at least 85% coverage of eligible populations. From 1989 to 2016, 11 741 276 ivermectin treatments have been given in the Americas, eliminating transmission in 11 of 13 foci. The OEPA's success has had a great influence on programs in Africa, especially Sudan and Uganda, which moved from a control to an elimination strategy in 2006 and 2007, respectively. The successes in the Americas have also greatly influenced WHO guidelines for onchocerciasis transmission elimination. With four of the six originally endemic American countries now WHO verified as having eliminated onchocerciasis transmission, and 95% of ivermectin treatments in the region halted, the regional focus is now on the remaining active transmission zone, called the Yanomami Area, on the border between Venezuela and Brazil. Both countries have difficult political climates that hinder the eli...Continue Reading
References
Aug 11, 1992·The American Journal of Tropical Medicine and Hygiene·R C CollinsE W Cupp
Sep 12, 1998·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·J BlanksM Jacox
Sep 26, 2008·Annals of Tropical Medicine and Parasitology·M Sauerbrey
Apr 1, 2009·PLoS Neglected Tropical Diseases·Rodrigo J GonzalezKim A Lindblade
Jul 3, 2010·The American Journal of Tropical Medicine and Hygiene·Mario A Rodríguez-PérezVidal García Rendón
Aug 31, 2010·Acta Tropica·E W CuppF Richards
Sep 13, 2012·Journal of Parasitology Research·Nancy Cruz-OrtizNidia Rizzo
Jul 15, 2015·PLoS Neglected Tropical Diseases·Mario A Rodríguez-PérezThomas R Unnasch
Oct 28, 2015·The American Journal of Tropical Medicine and Hygiene·Frank RichardsAlfredo Domínguez
Jan 28, 2016·Parasites & Vectors·Carlos BottoMaría Eugenia Grillet
Jun 25, 2016·PLoS Neglected Tropical Diseases·Frank O RichardsNidia Rizzo
Citations
Dec 7, 2019·Tropical Medicine & International Health : TM & IH·Wolfram G MetzgerPeter G Kremsner
Jan 17, 2019·Parasites & Vectors·Lassane KoalaRoch K Dabiré
Jul 16, 2019·Infectious Diseases of Poverty·Frank O RichardsMoses Katabarwa
Jan 31, 2020·Frontiers in Genetics·Shannon M HedtkeWarwick N Grant
Jul 11, 2020·Infectious Diseases of Poverty·John P EhrenbergJürg Utzinger
May 24, 2019·Scientific Data·Elex HillElizabeth A Cromwell
Jul 28, 2020·Expert Review of Anti-infective Therapy·Philip MiltonMaría-Gloria Basáñez
Aug 26, 2020·The American Journal of Tropical Medicine and Hygiene·Ángel GuevaraThomas R Unnasch
Sep 23, 2020·The American Journal of Tropical Medicine and Hygiene·Lindsay J RakersFrank O Richards
Oct 30, 2020·Research and Reports in Tropical Medicine·Thomson LakwoDidier Bakajika
Aug 29, 2020·Acta Tropica·Norbert W BrattigRolf Garms
May 25, 2021·International Journal for Parasitology. Drugs and Drug Resistance·Sandra NoackPaul M Selzer
Jun 4, 2021·Research and Reports in Tropical Medicine·Thuy-Huong Ta-TangJosé M Rubio
Apr 29, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yannick Niamsi-EmalioJoseph Kamgno
Apr 29, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Wilma A StolkMaría-Gloria Basáñez
Jul 29, 2021·PLoS Neglected Tropical Diseases·Elizabeth A CromwellDavid M Pigott
Oct 13, 2021·PLoS Neglected Tropical Diseases·Joseph PryceLisa J Reimer
Oct 14, 2021·Parasitology Research·Adela NgwewondoSabine Specht
Oct 16, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jérémy T CampilloCédric B Chesnais
Dec 7, 2021·Frontiers in Immunology·Anna WiszniewskyManuel Ritter